Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases
Open Access
- 31 October 2004
- journal article
- case report
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 51 (4), 580-584
- https://doi.org/10.1016/j.jaad.2004.05.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Etanercept therapy in patients with autoimmunity and hepatitis CJournal of Dermatological Treatment, 2003
- Etanercept as Monotherapy in Patients with PsoriasisThe New England Journal of Medicine, 2003
- Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trialArthritis & Rheumatism, 2003
- Effect of tumour necrosis factor antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infectionAnnals Of The Rheumatic Diseases, 2003
- Changing paradigms in dermatology: tumor necrosis factor alpha (tnf-α) blockade in psoriasis and psoriatic arthritisClinics in Dermatology, 2003
- Anti-TNF-α therapies: the next generationNature Reviews Drug Discovery, 2003
- Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typeArthritis & Rheumatism, 2003
- Overview of the use of the anti-TNF agent infliximab in chronic inflammatory diseasesExpert Opinion on Biological Therapy, 2003
- Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesionsClinical and Experimental Immunology, 1994
- Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis.The Journal of Experimental Medicine, 1994